Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment
Studies Test New Agents Offering Relief From Treatment-Related Side Effects
Oral UFT Equivalent To FULV In Stage II and III Colon Cancer
Adjuvant Chemo Improves Survival In Early Lung Cancer
Treat Cancer, But Protect Heart Anderson Cardiologists Warn
NCI-Approved Clinical Trials
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - “There is no safe harbor:” FY26 funding bill collapses after ICE shooting of Alex Pretti
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer - Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill









